Provides detailed information on the novel drug class SGLT2 inhibitors for the treatment of diabetes. All current evidences studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes.